title: Development of a flexible strategy towards FR900482 and the mitomycins.
abstract: FR900482 and the mitomycins are two intriguing classes of alkaloid natural products that have analogous biological mechanisms and obvious structural similarity. Both classes possess potent anticancer activity, a feature that has led to their investigation and implementation for the clinical treatment of human cancer. Given the structural similarity between these natural products, we envisioned a common synthetic strategy by which both classes could be targeted through assembling the mitomycin skeleton prior to further oxidative functionalization. Realization of this strategy with respect to FR900482 was accomplished through the synthesis of 7-epi-FR900482, which displayed equal potency relative to the natural product against two human cancer cell lines. With the challenging goal of a synthesis of either mitomycin or FR900482 in mind, several methodologies were explored. While not all of these methods ultimately proved useful for our synthetic goal, a number of them led to intriguing findings that provide a more complete understanding of several methodologies. In particular, amination via π-allyl palladium complexes for the synthesis of tetrahydroquinolines, eight-membered heterocycle formation via carbonylative lactamization, and amination through late-stage C-H insertion via rhodium catalysis all featured prominently in our synthetic studies.
authors: Department of Chemistry, Stanford University, Stanford, CA 94305-5080, USA. bmtrost@stanford.edu
authors: Barry M
authors: BM
authors: Trost
authors: Brendan M
authors: BM
authors: O'Boyle
authors: Wildeliz
authors: W
authors: Torres
authors: Michael K
authors: MK
authors: Ameriks
references: Angew Chem Int Ed Engl. 2003 Jul 7;42(26):3023-6
references: 12851961
references: Cancer Res. 1988 Mar 1;48(5):1166-72
references: 3342397
references: Org Lett. 2001 Aug 9;3(16):2575-8
references: 11483064
references: Chem Biol. 2000 Oct;7(10):805-12
references: 11033083
references: Biochemistry. 2003 Dec 16;42(49):14696-701
references: 14661983
references: J Med Chem. 1992 May 29;35(11):1954-68
references: 1534584
references: Angew Chem Int Ed Engl. 2001 Feb 2;40(3):598-600
references: 29712035
references: J Am Chem Soc. 2004 Sep 1;126(34):10682-91
references: 15327327
references: J Org Chem. 2004 Apr 16;69(8):2831-43
references: 15074935
references: Cancer Treat Rev. 2001 Feb;27(1):35-50
references: 11237776
references: J Am Chem Soc. 2002 Feb 6;124(5):754-5
references: 11817942
references: J Am Chem Soc. 2001 Jul 18;123(28):6801-8
references: 11448184
references: Org Lett. 2004 May 27;6(11):1745-8
references: 15151404
references: Org Lett. 2006 Sep 28;8(20):4493-6
references: 16986933
references: Chemistry. 2010 Aug 23;16(32):9772-6
references: 20669198
references: Invest New Drugs. 1991 Nov;9(4):377-82
references: 1804817
references: Chem Biol. 1997 Feb;4(2):127-37
references: 9190287
references: J Am Chem Soc. 2005 Sep 28;127(38):13156-7
references: 16173738
references: J Am Chem Soc. 2005 Mar 30;127(12):4297-307
references: 15783211
references: Angew Chem Int Ed Engl. 2002 Dec 16;41(24):4686-8
references: 12481326
references: Bioorg Med Chem. 2004 Jan 2;12(1):103-12
references: 14697775
references: J Am Chem Soc. 2003 Sep 24;125(38):11514-5
references: 13129351
references: J Org Chem. 2004 Apr 16;69(8):2825-30
references: 15074934
references: Angew Chem Int Ed Engl. 2002 Dec 16;41(24):4683-5
references: 12481325
references: Org Lett. 2003 Mar 20;5(6):785-7
references: 12633071
references: J Am Chem Soc. 2006 Mar 29;128(12):3931-3
references: 16551099
references: Org Lett. 1999 Sep 9;1(5):823-4
references: 10823211
references: Angew Chem Int Ed Engl. 2004 Jul 26;43(30):3890-908
references: 15274210
references: J Am Chem Soc. 2007 May 23;129(20):6470-6
references: 17461583
references: Angew Chem Int Ed Engl. 2007;46(32):6123-5
references: 17623279
references: Curr Opin Drug Discov Devel. 2001 Jul;4(4):435-49
references: 11727309
references: Org Lett. 2008 Apr 3;10(7):1369-72
references: 18318539
references: J Am Chem Soc. 2004 Feb 4;126(4):998-9
references: 14746449
references: J Org Chem. 2003 Jan 10;68(1):130-8
references: 12515471
references: Chem Rev. 2003 May;103(5):1979-2017
references: 12744698